FRANKFURT (Reuters) - German software company SAP is looking to recruit people with autism as programmers and product testers, drawing on skills that can include a close attention to detail and an ability to solve complex problems. SAP has asked start-up Danish recruitment company Specialisterne to help it find, train and manage employees diagnosed with the disability. "They bring a special set of skills to the table, which fits with SAP," said a spokesman for the company, which has already hired people with autism in India and Ireland. ...
(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount. Pfizer, the largest U.S. drugmaker, sold Zoetis shares in an initial public offering in February that raised $2.2 billion. Pfizer retained an 80 percent stake in Zoetis after the IPO and now plans to unwind that, starting with this offer. ...
By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America's Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...
By Ben Hirschler LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its kind between Washington and a drug company, will allow funding to move around GSK's antibiotics portfolio rather than focusing on a single drug candidate. ...
By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names. It first surfaced last year as "human betacoronavirus 2c EMC", but the suffixes "2c England-Qatar, "2C Jordan-N3", "England 1" have also appeared and many scientists have resorted to "novel coronavirus" - new crown-shaped virus - instead. ...
By Alex Dobuzinskis LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale of pot for health reasons, election returns early on Wednesday showed. The proposal appeared headed for passage. Returns showed 63 percent of voters supporting it compared with 37 percent opposed, after tabulation of more than 40 percent of ballots cast at polling stations on Tuesday, and all of the mail-in ballots received as of last Friday. ...
(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff competition from makers of less-costly generics. Under the accelerated share repurchase agreement (ASR), Merck has agreed to repurchase about 99.5 million shares from Goldman Sachs based on current market prices. ...
(Reuters) - Vivian Cheruiyot is not defending her world 5,000 and 10,000 meters gold medals in Moscow in August because she is expecting her first child, the Kenyan said in a statement. The 29-year-old, who won both races at the 2011 world athletics championships in Daegu, South Korea, took silver and bronze in the 5,000 and 10,000 at last year's London Olympics. In a statement released by her agent Ricky Simms on Wednesday, Cheruiyot said she would resume her career next year. She had first revealed her decision not to compete in Moscow on Tuesday but gave no reason for her absence. ...
By Stephanie Nebehay GENEVA (Reuters) - The H7N9 virus appears to have been brought under control in China largely due to restrictions at bird markets, but caused some $6.5 billion in losses to the economy, U.N. experts said on Tuesday. Health authorities worldwide must be on the lookout to detect the virus, the experts said, which could still develop the ability to spread easily among humans and cause a deadly influenza pandemic. ...





